Cara Therapeutics Statistics Share Statistics Cara Therapeutics has 1.52M
shares outstanding. The number of shares has increased by 0.57%
in one year.
Shares Outstanding 1.52M Shares Change (YoY) 0.57% Shares Change (QoQ) 0.1% Owned by Institutions (%) 0.05% Shares Floating 1.3M Failed to Deliver (FTD) Shares 36 FTD / Avg. Volume 0.46%
Short Selling Information The latest short interest is 71.02K, so 0% of the outstanding
shares have been sold short.
Short Interest 71.02K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1.54
Valuation Ratios The PE ratio is -11.82 and the forward
PE ratio is -0.62.
Cara Therapeutics's PEG ratio is
0.4.
PE Ratio -11.82 Forward PE -0.62 PS Ratio 117.38 Forward PS 0.8 PB Ratio -182.39 P/FCF Ratio -13.52 PEG Ratio 0.4
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Cara Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 11.03,
with a Debt / Equity ratio of 0.
Current Ratio 11.03 Quick Ratio 10.81 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -6.89
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $713.7K Profits Per Employee $-7.09M Employee Count 10 Asset Turnover 0.16 Inventory Turnover 0.69
Taxes Income Tax -398K Effective Tax Rate 0.56%
Stock Price Statistics The stock price has increased by -52.33% in the
last 52 weeks. The beta is 0.41, so Cara Therapeutics's
price volatility has been higher than the market average.
Beta 0.41 52-Week Price Change -52.33% 50-Day Moving Average 15.2 200-Day Moving Average 12.63 Relative Strength Index (RSI) 55.82 Average Volume (20 Days) 7,889
Income Statement In the last 12 months, Cara Therapeutics had revenue of 7.14M
and earned -70.87M
in profits. Earnings per share was -1.55.
Revenue 7.14M Gross Profit 6.52M Operating Income -58.38M Net Income -70.87M EBITDA -62.6M EBIT -62.79M Earnings Per Share (EPS) -1.55
Full Income Statement Balance Sheet The company has 37.9M in cash and 0 in
debt, giving a net cash position of 37.9M.
Cash & Cash Equivalents 37.9M Total Debt n/a Net Cash n/a Retained Earnings -755.61M Total Assets 43.75M Working Capital 32.45M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -60.92M
and capital expenditures -1.05M, giving a free cash flow of -61.96M.
Operating Cash Flow -60.92M Capital Expenditures -1.05M Free Cash Flow -61.96M FCF Per Share -1.36
Full Cash Flow Statement Margins Gross margin is 91.31%, with operating and profit margins of -818.03% and -992.95%.
Gross Margin 91.31% Operating Margin -818.03% Pretax Margin -998.53% Profit Margin -992.95% EBITDA Margin -877.12% EBIT Margin -818.03% FCF Margin -868.19%
Dividends & Yields CARA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for CARA.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Apr 16, 2025. It was a
backward
split with a ratio of 1:3.
Last Split Date Apr 16, 2025 Split Type backward Split Ratio 1:3
Scores Altman Z-Score -3.51 Piotroski F-Score 2
